Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Blay, Jean-Yves, Serrano, César, Heinrich, Michael C, Zalcberg, John, Bauer, Sebastian, Gelderblom, Hans, Schöffski, Patrick, Jones, Robin L, Attia, Steven, D'Amato, Gina, Chi, Ping, Reichardt, PeteJournal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30168-6
Date:
June, 2020
File:
PDF, 1.07 MB
2020